Insights On Solid Dose Manufacturing

1. Rheological Properties Of Pharmaceutical Excipients: Lactose Monohydrate And Carboxymethyl Cellulose 12/30/2024

   Explore lactose monohydrate and CMC rheology, highlighting their flow, cohesion, and compressibility properties to optimize pharmaceutical formulations under varying stress and temperature conditions.

2. Safely Scaling High Potency API Manufacturing 4/13/2026

   Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up.

3. Modern Containment Solutions In OSD Processes 6/15/2026

   Outdated containment infrastructure in OSD facilities creates costly compliance gaps and operational bottlenecks. Flexible single-use isolator systems offer a faster, more adaptable path forward.

4. The Future Of Pharma Packaging Trends, Technologies, And Patient-Centric Solutions 4/14/2026

   Pharmaceutical packaging must evolve alongside drug development to ensure stability, safety, and regulatory adherence, utilizing innovative designs to improve therapeutic outcomes and patient accessibility.

5. Compaction Simulation For Tablet Technology Transfer And Scale-Up 7/15/2026

   Compaction simulation de-risked tech transfer for a 40 mg fexuprazan tablet by defining optimal roller compaction and lubrication parameters before scale-up. Access the full case study to see the data.

6. How Is Peptide Crystallization Screening Used In Peptide-Based Therapeutic Development? 7/24/2026

   Hannah McLachlan, Project Scientist IV at Cambrex Edinburgh, on what crystallization screening delivers for peptide therapeutics — more stable material, higher purity, and a molecule clients can store without specialist infrastructure.

7. Benefits Of Single-Use Isolators For Cytotoxic Payload Handling 6/15/2026

   Managing cytotoxic ADC payloads in shared containment facilities creates mounting compliance, safety, and operational costs that single-use isolator technology is designed to address.

8. The Future Of Oral Solid Dose Development And Innovation 2/27/2025

   Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

9. Advances In Oral GLP-1 Analogs For Obesity 9/12/2024

   Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.

10. Spray Dry Biologics For Oral Dosage Forms 5/15/2026

    Spray drying enables stable oral delivery of biologics by creating protective dry powders, improving bioavailability, stability, and targeted release compared with traditional formulation methods.